Actinic keratosis

光化性角化病
  • 文章类型: Journal Article
    光化性角化病(AK)分类依赖于局限于皮肤表面的临床特征。结合表面下评估可以改善临床分类和潜在病理学之间的联系。我们旨在应用动态光学相干断层扫描(D-OCT)来表征AKI-III和光损伤(PD)皮肤中的微血管,从而探索其在增强临床和皮肤镜AK评估中的实用性。这项探索性研究评估了面部或头皮上的AKI-III和PD。根据Olsen方案对AK进行分级,然后用皮肤镜检查和D-OCT进行评估。在D-OCT上,血管形状,-模式和-方向在预定义的深度进行了定性评估,同时对密度和直径进行了量化。将D-OCT区分AK分级的能力与皮肤镜检查进行了比较。纳入47例AKI-III(n=207)和PD(n=87)患者。定性D-OCT评估显示AK等级和PD之间的血管差异,特别是在300μm的深度。毛囊周围血管形状的排列将AKII与PD区分开(OR=4.75,p<0.001)。AK等级和PD之间的船舶模式不同,显示AKI和PD的结构化模式,在AKII中无特异性(OR=2.16,p=0.03),在AKIII中斑驳(OR=29.94,p<0.001)。船方向在AKII-III中改变,在AKIII中最常见的是中央血管加重和辐射血管。AKI-II的量化血管密度高于PD(p≤0.025),而直径保持恒定。D-OCT结合皮肤镜检查可以精确区分AKIII与AKI(AUC=0.908)和II(AUC=0.833)。在D-OCT上对血管的定性和定量评估一致显示,在较高等级的AK病变中,血管形成和血管解体增加。
    Actinic keratosis (AK) classification relies on clinical characteristics limited to the skin\'s surface. Incorporating sub-surface evaluation may improve the link between clinical classification and the underlying pathology. We aimed to apply dynamic optical coherence tomography (D-OCT) to characterize microvessels in AK I-III and photodamaged (PD) skin, thereby exploring its utility in enhancing clinical and dermatoscopic AK evaluation. This explorative study assessed AK I-III and PD on face or scalp. AK were graded according to the Olsen scheme before assessment with dermatoscopy and D-OCT. On D-OCT, vessel shapes, -pattern and -direction were qualitatively evaluated at predefined depths, while density and diameter were quantified. D-OCT\'s ability to differentiate between AK grades was compared with dermatoscopy. Forty-seven patients with AK I-III (n = 207) and PD (n = 87) were included. Qualitative D-OCT evaluation revealed vascular differences between AK grades and PD, particularly at a depth of 300 μm. The arrangement of vessel shapes around follicles differentiated AK II from PD (OR = 4.75, p < 0.001). Vessel patterns varied among AK grades and PD, showing structured patterns in AK I and PD, non-specific in AK II (OR = 2.16,p = 0.03) and mottled in AK III (OR = 29.94, p < 0.001). Vessel direction changed in AK II-III, with central vessel accentuation and radiating vessels appearing most frequently in AK III. Quantified vessel density was higher in AK I-II than PD (p ≤ 0.025), whereas diameter remained constant. D-OCT combined with dermatoscopy enabled precise differentiation of AK III versus AK I (AUC = 0.908) and II (AUC = 0.833). The qualitative and quantitative evaluation of vessels on D-OCT consistently showed increased vascularization and vessel disorganization in AK lesions of higher grades.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Editorial
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Letter
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    在进行鳞状细胞癌及其前体的皮肤镜检查时,我们区分与角蛋白相关的,血管,和颜料相关的标准。非色素光化性角化病的特征是“草莓图案”。色素性光化性角化病显示皮肤镜检查与恶性扁桃体明显重叠,但是色素鳞片的存在,红斑,和突出的卵泡有利于其诊断。Bowen病的特点是聚集的肾小球血管,白色黄色鳞片,和棕色或灰色的点排列在其色素变体中的线条。最后,皮肤镜检查使我们能够在早期发现浸润性鳞状细胞癌,并将其与前体区分开来。此外,它的表现可能会有所不同,取决于分化的程度,与角蛋白相关的标准在明确界定的肿瘤中占主导地位,而不典型的血管模式将在低分化肿瘤中占主导地位。
    When performing the dermoscopy of squamous cell carcinoma and its precursors we differentiate among keratin-related, vascular, and pigment-related criteria. Non-pigmented actinic keratoses are characterized by the \"strawberry pattern\". Pigmented actinic keratosis shows a significant dermatoscopic overlap with lentigo maligna, but the presence of pigmented scales, erythema, and prominent follicles favors its diagnosis. Bowen\'s disease is characterized by clustered glomerular vessels, white-yellowish scales, and brown or grey dots arranged in lines in its pigmented variant. Finally, dermoscopy allows us to detect invasive squamous cell carcinoma in its early stages and differentiate it from its precursors. Furthermore, its presentation may vary depending on the degree of differentiation, with keratin-associated criteria predominating in well-demarcated tumors, while the atypical vascular pattern will predominate in poorly differentiated tumors.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    光动力疗法(PDT)是光化性角化病(AK)的有效治疗方法,并使用不同的光源以及光敏剂。此外,PDT通常与其他物理治疗或药物组合。
    本研究旨在通过进行网络荟萃分析(NMA),比较基于完全反应(CR)的不同PDT对AK病变的疗效。
    筛选了使用PDT进行AK的随机对照试验(RCT),并开发了贝叶斯模型以在首次治疗后3个月进行CR的NMA。
    纳入了26项试验,涉及2285名患者和14种治疗方法。治疗大致分为单PDT和联合治疗。光动力单一疗法包括甲基5-氨基乙酰丙酸(MAL)-日光(DL)-PDT,MAL-发光二极管(LED)-PDT,5-氨基乙酰丙酸(ALA)-LED-PDT,等。联合治疗包括消融点阵激光(AFL)辅助MAL-LED-PDT,卡泊三醇(CAL)辅助MAL-LED-PDT,和5-氟尿嘧啶(5-Fu)辅助的MAL-DL-PDT。NMA的结果表明,AFL-MAL-LED-PDT很有可能是最有效的治疗选择,其次是CAL-MAL-LED-PDT和ALA-LED-PDT。亚组分析显示,基于MAL的PDT在使用LED时优于其他光源,而与其他光敏剂相比,使用ALA时,基于LED的PDT可能具有更好的疗效。
    此NMA的结果表明,AFL-MAL-LED-PDT可能是实现AK病变完全清除的较优选择。使用LED作为光源和ALA作为光敏剂的PDT对于AK的治疗可能更有效。然而,需要更多的随机对照试验来验证本分析的结果.
    UNASSIGNED: Photodynamic therapy (PDT) is an effective treatment for actinic keratosis (AK) and uses different light sources as well as photosensitizers. In addition, PDT is often combined with other physical therapies or drugs.
    UNASSIGNED: This study was aimed to compare the efficacy of different PDTs against AK lesions based on Complete Response (CR) by conducting a network meta-analysis (NMA).
    UNASSIGNED: Randomized controlled trials (RCTs) using PDT for AK were screened and a Bayesian model was developed to perform an NMA of CR at 3 months after the first treatment.
    UNASSIGNED: Twenty-six trials involving 2285 patients and 14 treatments were included. The treatments were broadly divided into mono-PDT and combination therapy. The photodynamic monotherapies included methyl 5-aminolevulinic acid (MAL)-daylight (DL)-PDT, MAL-light-emitting diode (LED)-PDT, 5-aminolevulinic acid (ALA)-LED-PDT, etc. Combination therapies included ablative fractional laser (AFL)-assisted MAL-LED-PDT, calcipotriol (CAL)-assisted MAL-LED-PDT, and 5-fluorouracil (5-Fu)-assisted MAL-DL-PDT. The results of the NMA showed that there is a high probability that AFL-MAL-LED-PDT is the most effective treatment option, followed by CAL-MAL-LED-PDT and ALA-LED-PDT. The subgroup analysis showed that MAL-based PDT had better efficacy when using LED versus other light sources, while LED-based PDT was likely to have better efficacy when using ALA versus other photosensitizers.
    UNASSIGNED: The results of this NMA suggest that AFL-MAL-LED-PDT may be the superior choice for achieving complete clearance of AK lesions. PDT using LED as the light source and ALA as the photosensitizer may be more effective for the treatment of AK. However, more RCTs are needed to verify the results of this analysis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    非黑色素细胞皮肤癌(NMSC)是目前最常见的一组人类癌症,并且包括不是黑素瘤的所有肿瘤。在过去的几年里,暴露在阳光下的增加,缺乏定期和正确使用防晒霜,人口老龄化,更好的筛查技术是他们诊断升级的原因。鳞状细胞癌(SCC)占该组肿瘤的近37%,可以起源于光化性角化病(AK),通常表现为粉红色,通常是鳞状斑块,通常位于面部或头皮上。皮肤镜检查的进展,以及其他非侵入性皮肤成像模式的发展,如高频超声(HFUS),反射共聚焦显微镜(RCM),光学相干断层扫描(OCT),大大提高了诊断这些病变和监测其治疗的灵敏度。由于AK治疗通常是局部的,SCCs必须手术切除,非侵入性成像方法能够正确鉴定困难病变。这一点尤其重要,因为它们通常位于脸上,在这一领域的治疗后达到适当的美容效果对患者非常重要。在这次审查中,作者描述了非侵入性皮肤成像方法在光化性角化病诊断中的应用。
    Nonmelanocytic skin cancers (NMSCs) are currently the most common group of human cancers and include all tumors that are not melanomas. Increased exposure to sunlight over the past few years, the lack of regular and proper use of sunscreen, the aging of the population, and better screening techniques are the reasons for the escalation in their diagnosis. Squamous cell carcinoma (SCC) comprises nearly 37% of the tumors in this group and can originate from actinic keratosis (AK), which usually presents as pink, often scaly plaques, usually located on the face or scalp. Advances in dermatoscopy, as well as the development of other non-invasive skin imaging modalities such as high-frequency ultrasound (HFUS), reflectance confocal microscopy (RCM), and optical coherence tomography (OCT), have allowed for greatly increased sensitivity in diagnosing these lesions and monitoring their treatment. Since AK therapy is usually local, and SCCs must be removed surgically, non-invasive imaging methods enable to correctly qualify difficult lesions. This is especially important given that they are very often located on the face, and achieving an appropriate cosmetic result after treatments in this area is very important for the patients. In this review, the authors describe the use of non-invasive skin imaging methods in the diagnosis of actinic keratosis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    紫外线辐射(UVR)对人体皮肤的有害影响有据可查,包括DNA损伤,氧化应激,和致癌风险增加。传统的光保护措施主要依靠过滤器,散射或吸收紫外线辐射,但未能解决暴露后造成的细胞损伤。为了填补这个空白,抗氧化分子和DNA修复酶已被广泛研究,提供了朝着能够防止和逆转紫外线引起的损害的主动光保护的范式转变。在当前的审查中,我们专注于“主动光保护”,评估最先进的技术,有关使用DNA修复酶和天然抗氧化剂分子的临床试验和体内模型的最新进展和科学数据。
    The detrimental effects of ultraviolet radiation (UVR) on human skin are well-documented, encompassing DNA damage, oxidative stress, and an increased risk of carcinogenesis. Conventional photoprotective measures predominantly rely on filters, which scatter or absorb UV radiation, yet fail to address the cellular damage incurred post-exposure. To fill this gap, antioxidant molecules and DNA-repair enzymes have been extensively researched, offering a paradigm shift towards active photoprotection capable of both preventing and reversing UV-induced damage. In the current review, we focused on \"active photoprotection\", assessing the state-of-the-art, latest advancements and scientific data from clinical trials and in vivo models concerning the use of DNA-repair enzymes and naturally occurring antioxidant molecules.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:对光化性角化病(AK)的护理可以随着对指征疗法的相对效果的更多了解而得到改善。
    目的:使用网络荟萃分析,我们定量确定了成人面部和头皮AK患者干预措施的比较“短期”效果。
    方法:2023年2月28日,从OVID系统获得了同行评审文献的证据,Cochrane对照试验和临床试验中央登记册我们分析了以英语发表的研究数据,一个试验设计,并研究光化性角化病单一疗法的效果。患者完全清除,在治疗后8~12周,我们对成人患者的部分清除或病变特异性清除进行了分析.患者完全清除涉及经历光化性角化病病变完全清除的参与者的比例;患者部分清除对应于实现光化性角化病病变至少75%清除的受试者的百分比;病变特异性清除代表所有被清除的病变的百分比。在主要(即,基础)分析,节点仅在代理级别进行分析。
    结果:使用了来自总共84项研究的数据,其中确定了22种活性剂。估计了累积排名曲线排名下的干预措施表面和(成对)相对效果。在这三个结果中,5%的氟尿嘧啶是最有效的。
    结论:我们的工作首次提供了光化性角化病治疗(包括最近报道的治疗方法)对面部和头皮的协变量调整相对效果的信息;这些知识可能有助于医生和患者做出更明智的决定。
    BACKGROUND: Care for actinic keratosis (AK) can be improved with more knowledge on the relative of effect of indicated therapies.
    OBJECTIVE: Using network meta-analyses, we quantitatively determined the comparative \"short-term\" effects of interventions in adults with facial and scalp AK.
    METHODS: On February 28, 2023, evidence from the peer-reviewed literature was systematically obtained from OVID, the Cochrane Central Register of Controlled Trials and ClinicalTrials.gov. We analyzed data from studies published in English, of a trial design, and investigating the effect of an actinic keratosis monotherapy. Patient complete clearance, patient partial clearance or lesion-specific clearance across adults were analyzed at 8-12 weeks after therapy. Patient complete clearance pertained to proportion of participants who experienced complete clearance of actinic keratosis lesions; patient partial clearance corresponded to percentage of subjects who achieved at least 75% clearance of actinic keratosis lesions; lesion-specific clearance represented the percentage of all lesions that were cleared. In the main (i.e., base) analyses, nodes were analyzed only at the level of the agent.
    RESULTS: Data from a total of 84 studies were used-across which 22 active agents were identified. Estimates of interventions\' surface under the cumulative ranking curve rankings and (pairwise) relative effects were estimated. Across the three outcomes, fluorouracil 5% was ranked the most effective.
    CONCLUSIONS: Our work is the first to provide information on covariate-adjusted relative effects of actinic keratosis therapies- including the more recently reported treatments-for the face and scalp; this knowledge may help physicians and patients make more informed decisions.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:手突光化性角化病(AK)病变被认为难以治疗,关于这些病变的光动力疗法(PDT)的公开数据有限。因此,我们评估了持续的疗效,安全,PDT后对手上的AK的满意度。
    方法:我们分析了随机分组的手部治疗数据,双盲,个体内部III期研究。所有参与者先前都经历了多达两个具有10%5-氨基乙酰丙酸纳米乳液凝胶(BF-200ALA)的场定向红光PDT。评估包括PDT期间的疼痛,清除率和复发率,和满意度。
    结果:包括24名在手上治疗的参与者;分析了21名参与者。BF-200ALA的完全清除率为90.9%(基于病变)和76.2%(每个参与者侧),两者都明显高于车辆。BF-200ALA的病灶复发率为29.0%。不良事件反映了行动模式。在11分数字评定量表上,平均疼痛强度为4.8±3.8(BF-200ALA)和0.8±2.1(媒介物)。大多数参与者(81.0%)对BF-200ALA的满意度评价为非常好或良好。
    结论:此亚组分析表明,使用BF-200ALA的PDT为手部AK病变提供了合适的治疗方法。
    BACKGROUND: Acral actinic keratosis (AK) lesions are considered difficult to treat, and published data for photodynamic therapy (PDT) on these lesions is limited. Thus, we evaluated sustained efficacy, safety, and satisfaction after PDT for AK on the hands.
    METHODS: We analysed subgroup data for treatment on the hands from a randomised, double-blind, intra-individual phase III study. All participants previously underwent up to two field-directed red light PDTs with 10% 5-aminolevulinic acid nanoemulsion gel (BF-200 ALA). Assessments included pain during PDT, clearance and recurrence rates, and satisfaction.
    RESULTS: 24 participants treated on the hands were included; 21 participants were analysed. Complete clearance rates with BF-200 ALA were 90.9% (lesion-based) and 76.2% (per participant\'s side), both markedly higher than with vehicle. The lesion recurrence rate with BF-200 ALA was 29.0%. Adverse events reflected the mode of action. Mean pain intensities were 4.8 ± 3.8 (BF-200 ALA) and 0.8 ± 2.1 (vehicle) on an 11-point numeric rating scale. Most participants (81.0%) rated their satisfaction with BF-200 ALA as very good or good.
    CONCLUSIONS: This subgroup analysis indicates that PDT with BF-200 ALA provides a suitable treatment for AK lesions on the hands.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号